Molecular mechanism of angiotensin II-induced insulin resistance in aortic vascular smooth muscle cells: Roles of Protein Tyrosine Phosphatase-1B

Vascular Pharmacology

Volumn 53, Issue 3-4, 2010, Pages 160-168

  Ketsawatsomkron, Pimonrat ^a   Stepp, David W ^a   Fulton, David J ^a   Marrero, Mario B ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Angiotensin II; Growth; Insulin resistance; PTP 1B

Indexed keywords

ANGIOTENSIN II; ANTISENSE OLIGONUCLEOTIDE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; PROTEIN P42; PROTEIN TYROSINE PHOSPHATASE 1B; SERINE; TYROSINE;

ANIMAL CELL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; GENETIC TRANSFECTION; INSULIN RESISTANCE; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; AORTA; CELLS, CULTURED; ENZYME ACTIVATION; INSULIN; INSULIN RESISTANCE; MALE; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 77956186614     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2010.06.001     Document Type: Article

References (46)

1. Asante-Appiah E., Kennedy B.P. Protein tyrosine phosphatases: the quest for negative regulators of insulin action. Am. J. Physiol. Endocrinol. Metab. 2003, 284:E663-E670.
2. Bence K.K., Delibegovic M., Xue B., Gorgun C.Z., Hotamisligil G.S., Neel B.G., Kahn B.B. Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat. Med. 2006, 12:917-924.
3. Biddinger S.B., Kahn C.R. From mice to men: insights into the insulin resistance syndromes. Annu. Rev. Physiol. 2006, 68:123-158.
4. Brautigan D.L., Pinault F.M. Serine phosphorylation of protein tyrosine phosphatase (PTP1B) in HeLa cells in response to analogues of cAMP or diacylglycerol plus okadaic acid. Mol. Cell. Biochem. 1993, 127-128:121-129.
5. Byon J.C., Kusari A.B., Kusari J. Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction. Mol. Cell. Biochem. 1998, 182:101-108.
6. Carvalho C.R., Thirone A.C., Gontijo J.A., Velloso L.A., Saad M.J. Effect of captopril, losartan, and bradykinin on early steps of insulin action. Diabetes 1997, 46:1950-1957.
7. Cooper S.A., Whaley-Connell A., Habibi J., Wei Y., Lastra G., Manrique C., Stas S., Sowers J.R. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H2009-H2023.
8. Digicaylioglu M., Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 2001, 412:641-647.
9. Dube N., Cheng A., Tremblay M.L. The role of protein tyrosine phosphatase 1B in Ras signaling. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:1834-1839.
10. Duff J.L., Monia B.P., Berk B.C. Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. Effect of actinomycin D and antisense oligonucleotides. J. Biol. Chem. 1995, 270:7161-7166.
11. Dulin N.O., Niu J., Browning D.D., Ye R.D., Voyno-Yasenetskaya T. Cyclic AMP-independent activation of protein kinase A by vasoactive peptides. J. Biol. Chem. 2001, 276:20827-20830.
12. Elchebly M., Payette P., Michaliszyn E., Cromlish W., Collins S., Loy A.L., Normandin D., Cheng A., Himms-Hagen J., Chan C.C., Ramachandran C., Gresser M.J., Tremblay M.L., Kennedy B.P. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999, 283:1544-1548.
13. Esposito D.L., Li Y., Vanni C., Mammarella S., Veschi S., Della L.F., Mariani-Costantini R., Battista P., Quon M.J., Cama A. A novel T608R missense mutation in insulin receptor substrate-1 identified in a subject with type 2 diabetes impairs metabolic insulin signaling. J. Clin. Endocrinol. Metab. 2003, 88:1468-1475.
14. Flint A.J., Gebbink M.F., Franza B.R., Hill D.E., Tonks N.K. Multi-site phosphorylation of the protein tyrosine phosphatase, PTP1B: identification of cell cycle regulated and phorbol ester stimulated sites of phosphorylation. EMBO J. 1993, 12:1937-1946.
15. Florian J.A., Watts S.W. Integration of mitogen-activated protein kinase kinase activation in vascular 5-hydroxytryptamine2A receptor signal transduction. J. Pharmacol. Exp. Ther. 1998, 284:346-355.
16. Folli F., Kahn C.R., Hansen H., Bouchie J.L., Feener E.P. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J. Clin. Investig. 1997, 100:2158-2169.
17. Folli F., Saad M.J., Velloso L., Hansen H., Carandente O., Feener E.P., Kahn C.R. Crosstalk between insulin and angiotensin II signalling systems. Exp. Clin. Endocrinol. Diab. 1999, 107:133-139.
18. Gual P., Marchand-Brustel Y., Tanti J.F. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 2005, 87:99-109.
19. Henriksen E.J., Jacob S., Kinnick T.R., Teachey M.K., Krekler M. Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats. Hypertension 2001, 38:884-890.
20. Horiuchi M., Mogi M., Iwai M. Signaling crosstalk angiotensin II receptor subtypes and insulin. Endocr. J. 2006, 53:1-5.
21. Hsueh W.A., Lyon C.J., Quinones M.J. Insulin resistance and the endothelium. Am. J. Med. 2004, 117:109-117.
22. Ichiki T., Kambayashi Y., Inagami T. Differential inducibility of angiotensin II AT2 receptor between SHR and WKY vascular smooth muscle cells. Kidney Int. Suppl. 1996, 55:S14-S17.
23. Igarashi M., Hirata A., Nozaki H., Kadomoto-Antsuki Y., Tominaga M. Role of angiotensin II type-1 and type-2 receptors on vascular smooth muscle cell growth and glucose metabolism in diabetic rats. Diab. Res. Clin. Pract. 2007, 75:267-277.
24. Izawa Y., Yoshizumi M., Fujita Y., Ali N., Kanematsu Y., Ishizawa K., Tsuchiya K., Obata T., Ebina Y., Tomita S., Tamaki T. ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells. Exp. Cell Res. 2005, 308:291-299.
25. Jiang Z.Y., Lin Y.W., Clemont A., Feener E.P., Hein K.D., Igarashi M., Yamauchi T., White M.F., King G.L. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J. Clin. Investig. 1999, 104:447-457.
26. Krook A., Kawano Y., Song X.M., Efendic S., Roth R.A., Wallberg-Henriksson H., Zierath J.R. Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki rats. Diabetes 1997, 46:2110-2114.
27. Kuboki K., Jiang Z.Y., Takahara N., Ha S.W., Igarashi M., Yamauchi T., Feener E.P., Herbert T.P., Rhodes C.J., King G.L. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 2000, 101:676-681.
28. Marrero M.B., Schieffer B., Li B., Sun J., Harp J.B., Ling B.N. Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J. Biol. Chem. 1997, 272:24684-24690.
29. Marrero M.B., Venema V.J., Ju H., Eaton D.C., Venema R.C. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2. Am. J. Physiol. 1998, 275:C1216-C1223.
30. Marrero M.B., Fulton D., Stepp D., Stern D.M. Angiotensin II-induced insulin resistance and protein tyrosine phosphatases. Arterioscler. Thromb. Vasc. Biol. 2004, 24:2009-2013.
31. Navarro-Cid J., Maeso R., Perez-Vizcaino F., Cachofeiro V., Ruilope L.M., Tamargo J., Lahera V. Effects of losartan on blood pressure, metabolic alterations, and vascular reactivity in the fructose-induced hypertensive rat. Hypertension 1995, 26:1074-1078.
32. Nigro J., Osman N., Dart A.M., Little P.J. Insulin resistance and atherosclerosis. Endocr. Rev. 2006, 27:242-259.
33. Ogihara T., Asano T., Ando K., Chiba Y., Sakoda H., Anai M., Shojima N., Ono H., Onishi Y., Fujishiro M., Katagiri H., Fukushima Y., Kikuchi M., Noguchi N., Aburatani H., Komuro I., Fujita T. Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling. Hypertension 2002, 40:872-879.
34. Rashid N., Morin F.C., Swartz D.D., Ryan R.M., Wynn K.A., Wang H., Lakshminrusimha S., Kumar V.H. Effects of prostacyclin and milrinone on pulmonary hemodynamics in newborn lambs with persistent pulmonary hypertension induced by ductal ligation. Pediatr. Res. 2006, 60:624-629.
35. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
36. Shao J., Yamashita H., Qiao L., Friedman J.E. Decreased Akt kinase activity and insulin resistance in C57BL/KsJ-Leprdb/db mice. J. Endocrinol. 2000, 167:107-115.
37. Shaw S., Wang X., Redd H., Alexander G.D., Isales C.M., Marrero M.B. High glucose augments the angiotensin II-induced activation of JAK2 in vascular smooth muscle cells via the polyol pathway. J. Biol. Chem. 2003, 278:30634-30641.
38. Shaw S.S., Schmidt A.M., Banes A.K., Wang X., Stern D.M., Marrero M.B. S100B-RAGE-mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2. Diabetes 2003, 52:2381-2388.
39. Tao J., Malbon C.C., Wang H.Y. Insulin stimulates tyrosine phosphorylation and inactivation of protein-tyrosine phosphatase 1B in vivo. J. Biol. Chem. 2001, 276:29520-29525.
40. Wang C.C., Gurevich I., Draznin B. Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways. Diabetes 2003, 52:2562-2569.
41. Wright M.B., Seifert R.A., Bowen-Pope D.F. Protein-tyrosine phosphatases in the vessel wall: differential expression after acute arterial injury. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1189-1198.
42. Wu Y., Ouyang J.P., Wu K., Wang S.S., Wen C.Y., Xia Z.Y. Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats. Br. J. Pharmacol. 2005, 146:234-243.
43. Zeng G., Quon M.J. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J. Clin. Investig. 1996, 98:894-898.
44. Zeng G., Nystrom F.H., Ravichandran L.V., Cong L.N., Kirby M., Mostowski H., Quon M.J. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000, 101:1539-1545.
45. Zhuplatov S.B., Masaki T., Blumenthal D.K., Cheung A.K. Mechanism of dipyridamole's action in inhibition of venous and arterial smooth muscle cell proliferation. Basic Clin. Pharmacol. Toxicol. 2006, 99:431-439.
46. Zinker B.A., Rondinone C.M., Trevillyan J.M., Gum R.J., Clampit J.E., Waring J.F., Xie N., Wilcox D., Jacobson P., Frost L., Kroeger P.E., Reilly R.M., Koterski S., Opgenorth T.J., Ulrich R.G., Crosby S., Butler M., Murray S.F., McKay R.A., Bhanot S., Monia B.P., Jirousek M.R. PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:11357-11362.